QCLS
NASDAQ · Pharmaceuticals
Q/C Technologies Inc
$0.33
-0.06 (-14.53%)
Open$0.39
Previous Close$0.39
Day High$0.40
Day Low$0.31
52W High$8.17
52W Low$0.42
Volume—
Avg Volume132.4K
Market Cap3.56M
P/E Ratio—
EPS$-3.83
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.12M | 5.83M | 5.05M |
| Net Income | 729.3K | 769.8K | 662.9K |
| Profit Margin | 11.9% | 13.2% | 13.1% |
| EBITDA | 1.12M | 1.08M | 875.0K |
| Free Cash Flow | 457.4K | 470.8K | 287.5K |
| Rev Growth | +22.0% | +12.4% | +6.3% |
| Debt/Equity | 0.30 | 0.26 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |